Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Less than $10/month! Screen on your Watchlists and Portfolios with Barchart Plus. FREE 30 Day Trial
Stocks | Futures | Watchlist | More
or

Amyris Inc (AMRS)

Amyris Inc (AMRS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
News & Headlines for [[ item.sessionDateDisplayLong ]]
AMYRIS ANNOUNCES OPERATIONAL AND FINANCIAL RESTRUCTURING TO ADVANCE STRATEGIC TRANSFORMATION

/PRNewswire/ -- Amyris, Inc. (Nasdaq: AMRS) ("Amyris" or the "Company"), a leading synthetic biotechnology company accelerating the world's transition to...

AMRS : 0.0500 (-21.88%)
Is It Time to Buy This Year's Worst-Performing Growth Stocks?

Ready to make sense of the market's laggards? The share prices of these high-octane growth stocks are falling in 2023, so it might be time to bet on rebounds -- but only some of them.

CHGG : 2.96 (-2.31%)
JD : 27.47 (-3.14%)
ENPH : 103.25 (-4.42%)
ETSY : 59.79 (-0.27%)
AMRS : 0.0500 (-21.88%)
AMYRIS ANNOUNCES CEO TRANSITION AND GLOBAL REDUCTION IN FORCE

/PRNewswire/ -- Amyris, Inc. (Nasdaq: AMRS), a leading synthetic biotechnology company accelerating the world's transition to sustainable consumption through...

AMRS : 0.0500 (-21.88%)
AMYRIS INITIATES STRATEGIC TRANSFORMATION PROGRAM AND SECURES FUNDING

/PRNewswire/ -- Amyris, Inc. (Nasdaq: AMRS), a leading synthetic biotechnology company accelerating the world's transition to sustainable consumption through...

AMRS : 0.0500 (-21.88%)
AMYRIS COMPLETES LICENSE FOR SUPPLY OF SUSTAINABLE SQUALENE

EMERYVILLE, Calif., May 19, 2023 Amyris, Inc. (Nasdaq: AMRS), a leading synthetic biotechnology company accelerating the world's transition to sustainable...

AMRS : 0.0500 (-21.88%)
AMYRIS, INC. REPORTS FIRST QUARTER 2023 FINANCIAL RESULTS

/PRNewswire/ -- Amyris, Inc. (Nasdaq: AMRS), a leading synthetic biotechnology company accelerating the world's transition to sustainable consumption through...

AMRS : 0.0500 (-21.88%)
AMYRIS TO HOST FIRST QUARTER 2023 FINANCIAL RESULTS CONFERENCE CALL ON MAY 9

/PRNewswire/ -- Amyris, Inc. (Nasdaq: AMRS), a leading synthetic biotechnology company accelerating the world's transition to sustainable consumption through...

AMRS : 0.0500 (-21.88%)
Amyris May be Oversold, but is it Worth Fighting the Shorts?

Amyris is fighting a battle with short sellers, and with the economy either in, or nearing, a recession, there may be better options for speculative investors

AMRS : 0.0500 (-21.88%)
AMYRIS CLOSES STRATEGIC TRANSACTION WITH GIVAUDAN

/PRNewswire/ -- Amyris, Inc. (Nasdaq: AMRS), a leading synthetic biotechnology company accelerating the world's transition to sustainable consumption through...

AMRS : 0.0500 (-21.88%)
AMYRIS, INC. REPORTS FOURTH QUARTER AND FULL YEAR 2022 FINANCIAL RESULTS

Fourth quarter Consumer revenue of $52.8 million increased 64% over the prior year and was another record quarter. Core revenue of $75.8 million grew 17% over...

AMRS : 0.0500 (-21.88%)

Barchart Exclusives

Zeta Global Holdings or NuScale Power: Which Is the Better Top 100 Stock to Buy?
There were two new entrants in Barchart’s Top 100 Stocks to Buy in early Tuesday trading. Both have weighted alphas that are higher than their 52-week change in price. One is a better buy. Read more
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar